NFKB1 and neoplasm: Kuo and collaborators showed that a suicide gene therapy targeting the STAT3/ NFκB pathways in a TNBC cell line resulted in a reduction of tumor growth, loss of invasiveness and an enhanced sensitization of the TNBC cell line to cisplatin therapy [42].